STAT+: Pharmalittle: Abortion pills will be at center of legal battles; Gilead reaches $33 million settlement over patient assistance programs

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the predictable routine of online calls, deadlines, and meetings has returned. But you knew this would happen because the world keeps spinning no matter how hard we try to slow it down. So time to give it a nudge in a better direction with a cup or more of stimulation. Our choice today is bourbon pecan. Please feel free to join us. Meanwhile, here is the latest laundry list of interesting items for you to peruse. We hope your journey today is smooth and successful. And as always, do keep in touch. We appreciate saucy tips and insights. …

Abortion pills, already used in more than half of recent abortions in the U.S., are becoming even more sought-after in the aftermath of Roe v. Wade being overturned, and they will likely be at the center of the legal battles that are expected to unfold as about half the states ban abortion and others take steps to increase access, The New York Times explains. In the hours after the U.S. Supreme Court released its decision overturning the legal right to abortion in the United States, nearly 100 requests for appointments flowed into Just the Pill, a nonprofit organization that arranges for patients to obtain abortion pills in several states.

Continue to STAT+ to read the full story…

Read Original Article: STAT+: Pharmalittle: Abortion pills will be at center of legal battles; Gilead reaches $33 million settlement over patient assistance programs »